| (Values in U.S. Thousands) | Dec, 2025 | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 |
| Sales | 63,263 | 48,938 | 34,223 | 23,749 | 15,501 |
| Sales Growth | +29.27% | +43.00% | +44.10% | +53.21% | +108.86% |
| Net Income | -2,349 | -7,727 | -14,119 | -9,148 | -9,859 |
| Net Income Growth | +69.61% | +45.27% | -54.34% | +7.21% | -73.23% |
Kneat.com Inc (KSI.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
kneat.com Inc is in the business of developing and marketing a software application for modeling regulated data-intensive processes for regulated industries, focusing on the life sciences industry. The company has developed the Kneat Gx solution which provides management real-time visibility and control and increases product, quality, and compliance. In addition, it provides software-related services including training, installation, upgrades, consulting and maintenance, which include product support services. The company geographically operates in North America, Europe and Asia Pacific, out of which it earns maximum revenue from North America.
Fiscal Year End Date: 12/31